CDH17 and glioblastoma: In GBM, the alteration of cadherin expression is associated with a change in tumor phenotype and growth; in fact, it was demonstrated that the antagonism of VEGF pathway generates a switch from angiogenic to infiltrative pattern of growth and alteration in integrin expression and also by a T to N cadherin switch.